Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: Symposium Mammographicum 2006

Email this article to a friend

Audit of wide bore needle biopsies graded B3: does the final pathology justify the increasing rate of benign biopsy?

NR Wakeham, K Satchithananda and NK Barrett

Breast Cancer Research 2006, 8(Suppl 1):P9 doi:10.1186/bcr1424

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.